The HLA typing for the transplants market is projected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%. The growth of this market is primarily driven by the increasing number of transplantation procedures, technological advancements in the field of HLA typing, increasing public-private funding for target research activities, and the growing burden of infectious diseases that are driving the growth of the HLA typing for transplants market. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities—especially in emerging markets, which are expected to witness the highest growth.
Key Market Players
Some prominent players in the HLA typing for the transplants market are Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Illumina (US), Care Dx (US), and Immucor, Inc. (US). An analysis of the developments in the HLA typing for the transplants market from 2016–2019 showed that product launches, expansions, agreements, partnerships, collaborations, and acquisitions were the most widely adopted growth strategies in the market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742
Thermo Fisher Scientific is the leading player in the global HLA typing for the transplants market. The company has a broad range of automated instruments for antibody screening and analysis, semi-automated systems for serological assays, standalone systems & reagents for molecular and non-molecular assay procedures, including HLA typing products for transplant. The company focuses on launching technologically advanced products to maintain its leadership in the HLA typing for the transplants industry. Furthermore, the company focuses on strengthening its revenue growth and brand positioning by adopting strategies such as acquisitions and expansions. Pertaining to this, Thermo Fisher Scientific acquired several companies to enhance its presence in the market further. These acquisitions enabled the company to expand and strengthen its genomic analysis product portfolio as well as develop innovative diagnostic technologies.
QIAGEN ((Netherlands) holds a leading position in the HLA typing for the transplant industry due to its vast product portfolio in molecular diagnostics and analytics. Over the years, the company has focused on multiple growth strategies, such as agreements, collaborations, and product launches. Along with this, the company has maintained continuous leadership in the HLA typing for the transplants industry with its huge consumer base. It has also strengthened its R&D capabilities for the development of innovative HLA typing products for transplants to expand its consumer base and offer novel products.
Get 10% Customization on this Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=96374742
Key Questions Addressed by the Report:
· What are the growth opportunities related to the adoption of HLA typing for transplant products across significant regions in the future?
· Emerging countries show immense opportunities for the growth and adoption of HLA typing for transplant instruments, related reagents & consumables, and software. Will this scenario continue in the next five years?
· Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
· What are the newest trends and advancements in the HLA typing for the transplants market?
HLA Typing for Transplant Market Advantages:
1. Improved Organ Matching: HLA typing for transplant can improve organ matching by providing accurate results that can help to identify the right donor for an individual patient. This can help to reduce the risk of organ rejection and improve the chances of successful organ transplantation.
2. Cost Savings: HLA typing for transplant can help to reduce the cost associated with organ transplantation by ensuring that the right donor is identified quickly and efficiently. This can help to reduce the need for expensive tests that may not be necessary if the right organ donor is identified quickly.
3. Improved Quality of Life: With the improved organ matching that is provided by HLA typing for transplant, patients can experience improved quality of life after transplantation. This improved quality of life can help to reduce the risk of complications from the transplant and improve the patient's overall health and wellbeing.
Get Special Pricing on Bundle Reports:
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=96374742
Browse Related Reports:
Transplant Diagnostics Market - FORECAST TO 2025 by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End-User (Hospital)
https://www.marketsandmarkets.com/Market-Reports/global-transplant-diagnostics-market-2531061.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets' flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
